[HTML][HTML] The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a …
XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - journals.lww.com
Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic …
XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - europepmc.org
Background Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic …
XL Li, L Wang, F Lv, XM Huang, LP Wang… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
[HTML][HTML] The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A …
XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - ncbi.nlm.nih.gov
Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic …
XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - europepmc.org
Background Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …